Prostaglandin E,, 4 >ig/min, infused locally intra-arterially (ia) for 80 minutes into forelimbs perfused at constant pump controlled inflow produced decreases in perfusion pressure, increases in lymph total protein concentration ( s i g/100 ml), and small increases in weight (23 g) owing to edema formation. Histamine, 16 /ig base/min, or bradykinin, 10 >tg base/min, infused locally ia for 30 minutes produced large increases in lymph flow, lymph total protein concentration, total protein transport, and weight (70 g and 130 g, respectively). However, the local ia infusion of prostaglandin Ei, 4 fig/min, together with histamine, 16 /ig base/min, or bradykinin, 10 fig base/min, produced weight increases of 180 g and 236 g, respectively, and the rate of weight gain during the combination infusions greatly exceeded that produced by infusions of histamine or bradykinin alone. Moreover, the increases in lymph flow and in total protein transport far exceeded those produced by infusions of prostaglandin E, and histamine or bradykinin alone or additively. The edema produced by the local ia infusion of prostaglandin Ei, 4 fig/min, together with bradykinin, 10 pg base/min, was even more marked in naturally perfused forelimbs. Similarly, the local ia infusion of histamine, 4 /ig base/min, or bradykinin, 0.8 fig base/min, for 60 minutes into forelimbs perfused at constant inflow produced increases In lymph flow, lymph total protein concentration, total protein transport, and weight (38 g and 14 g, respectively). In contrast, histamine, 4 fig base/min, and bradykinin, 0.8 fig base/min, infused together locally ia for 60 minutes produced increases in weight of 118 g. The increase in lymph flow and total protein transport was considerably more marked during the combined infusions than during the infusions of histamine or bradykinin alone or additively. Circ Res 49: 298-306, 1S81
TISSUE swelling (edema) is one of the cardinal signs of inflammation. The edema is largely attributable to the direct action of released histamine, bradykinin, and possibly other substances on the microvascular membrane which produce an increase in microvascular permeability to macromolecules. This increases the efflux rate of plasma proteins from blood to tissue which decreases the transmural colloid osmotic pressure gradient promoting increased net fluid filtration. The increased fluid filtration is further enhanced by the arteriolar vasodilator action of these inflammatory mediators which increases blood flow, perfused surface area, and capillary hydrostatic pressure.
In more recent years, the prostaglandins have been added to the list of inflammatory mediators (Ferreira and Vane, 1974; Vane, 1976) . Prostaglandin E type compounds have been identified in inflammatory exudates (Willis, 1969; Hamberg and Jonsson, 1973; Plummer et al., 1977; Arturson, 1979) , and inhibitors of prostaglandin synthesis such as indomethacin and aspirin are potent antiinflammatory agents both experimentally and clinically (Ferreira and Vane, 1974; Chahl and Chahl, 1976; Vane, 1976; Plummer et al., 1977; Arturson, 1979) .
Surprisingly, the direct actions of prostaglandin E type compounds on the microvascular membrane are very weak compared to those of histamine and bradykinin (Williams and Morley, 1973; Vane, 1976; Svensjo, 1978) . Prostaglandin E, is reported to exert the most potent inflammatory action of the E type prostaglandins (Crunkhorn and Willis, 1971; Williams and Morley, 1973; Ikeda et al., 1975; Flower et al., 1976; Svensjo, 1978) . Based on this observation, it could be questioned whether the prostaglandins play an important role in the inflammatory process, yet the fact remains that the inhibitors of prostaglandin synthesis are potent anti-inflammatory agents. Other observations, however, suggest a way out of this dilemma. Several investigators have reported that prostaglandin Ei potentiates the inflammatory action of histamine and bradykinin (Williams and Morley, 1973; Ferreira et al., 1973; Lewis et al., 1974; Thomas and West, 1974; Vane, 1976; Williams and Peck, 1977; Svensjo, 1978) .
Most of the experimental data providing evidence for a role of the prostaglandins in inflammatory processes are from studies in rats or hamsters. Studies in the dog, though few in number, fail to provide evidence for a prostaglandin-induced increase in permeability to macromolecules owing to a direct action on the microvascular membrane (Greenberg and Sparks, 1969; Daugherty, 1971; Joyner, 1977) . Moreover, the potential interactions among the prostaglandins and other inflammatory mediators apparently have not been studied in the dog. The mechanism by which prostaglandin Ei potentiates the inflammatory actions of histamine and bradykinin is not clear. The interpretation of the data by Williams and Morley (1973) and Williams and Peck (1977) implies that the potentiation results simply from the potent arteriolar vasodilator action of prostaglandin Ei which further increases blood flow, perfused surface area, and microvascular pressure. In contrast, data presented by Svensjo (1978) and Joyner et al. (1979) demonstrate that the potentiation is independent of the arteriolar vasodilator actions of prostaglandin Ei. Instead, the potentiation results from a further increase in the number of large venular pores produced by the simultaneous infusion of prostaglandin Ei with histamine or bradykinin and produced by an unknown mechanism.
These observations prompted the present study to characterize the effects of prostaglandin Ei on macromolecular permeability and edema alone and in combination with other mediators of inflammation in the canine forelimb. Experiments were also designed to assess the role of increases in blood flow and macromolecular permeability in the potentiation of the inflammatory actions of histamine and bradykinin produced by prostaglandin Ei.
Methods
Mongrel dogs of either sex having an average weight of 23 kg (16-28 kg range) were anesthetized with sodium pentobarbital (30-35 mg/kg, iv) and ventilated using a Harvard respirator.
Lymph Flow Rate and Total Protein Concentration Measurements
Small incisions were made over the brachial artery, cephalic vein (above the elbow), and second superficial dorsal metacarpal vein (paw) in the right forelimb. A side branch of the brachial artery, a lymph vessel, and the vein were isolated. After intravenous administration of heparin (300 U/kg), these vessels were cannulated in an upstream direction with polyethylene tubing. The cannulas were used for drug administration, lymph collection, and pressure measurement, respectively. The lymph vessels in the area of the cephalic vein at the elbow drain forelimb skin and paw. Two or three lymph vessels were usually tied centrally, and one of them was cannulated distally with a 10-cm length of PE-10 tubing that had been beveled at the cannulating end.
Lymph was collected in miniature 0.5-ml graduated cylinders constructed from plastic pipettes. Drugs were infused into the brachial artery with a Harvard infusion pump. The skin small vein pressure and aortic pressure (via a femoral artery) were measured with low-volume displacement Statham pressure transducers (P23Gb). Blood was collected periodically from the brachial artery for plasma protein determinations. Lymph collections were made for 10-minute periods, and pressures were measured at the end of each period. Total protein concentration in lymph and plasma was measured by the spectrophotometric (Beckman DB spectrophotometer) method of Waddell (1956) .
Prostaglandin Ei, 4 /xg/min, or bradykinin, 10 fig base/min, was infused locally intra-arterially for 60 minutes. In other experiments, these agents were infused together ia for 60 minutes under similar conditions except that the prostaglandin Ei infusion was initiated 10 minutes prior to the bradykinin infusion.
In other dogs, a Masterflex roller pump was interposed in the brachial arterial circulation to maintain constant pump controlled blood inflow throughout the experiment. Initially, flow was set at a rate that produced a perfusion pressure similar to aortic pressure. Lymph and blood collections, pressure measurements, and drug infusions were as described above except that other doses or drugs were also studied.
Prostaglandin In other experiments, prostaglandin Ei was infused together with histamine, 16 /ig base/min, or bradykinin, 10 jug base/min, ia for 60 minutes under similar conditions except that the prostaglandin Ei infusion was initiated 10 minutes prior to the histamine or bradykinin infusion. In still other experiments, histamine, 4 \ig base/min, and bradykinin, 0.8 or 10 fig base/min, were infused together ia for 60 minutes.
All drugs were administered locally intra-arterially at a delivery rate of 0.2 ml/min using a Harvard infusion/withdrawal pump.
At the conclusion of the experiments the animals were killed. Immediately, the right and left forelimbs were severed approximately 2 cm above the humeral condyle. The brachialis, biceps, and triceps muscles were dissected down to their tendons of insertions on the ulnar and radial tuberosities. The humerus was cut and forelimbs were then exsanguinated and weighed. The mean weight differences between the experimental and contralateral control forelimbs were compared using the £-test. All other data were statistically analyzed using the Student-Newman-Keuls procedure (Sokal and Rohlf, 1969) .
Results

Responses in Forelimbs Perfused at Natural Flow
Effects of Prostaglandin E\ and Bradykinin
Alone and in Combination on Vascular Pressure, Lymph, and Weight (Table 1) Mean aortic pressure and plasma total protein concentration were not significantly affected during the local ia infusion of prostaglandin Ei, 4 /ig/min, /min , ia (n -6); bradykinin -10 jig base/min, la (n = 6); PGE, + bridykinin -(n -8). The mean weight of the experimental forelimba exceeded the mean weight of the contxalateral control forelimb* by 35 ± 6 g', 158 ± 13 g* T and 293 ± 27 g* following the cessation of the prostaglandin E, r bradykinin, and procuglandin E,-bradykinin infusions, respectively.
• P 5 0.01 relative to -20 to -10 minute time. t P 3 0.06 relative to -20 to -10 minute time.
and bradykinin, 10 /ig base/min, alone or in combination. Skin small vein pressure was increased throughout the infusion period in all three experimental groups, especially during the combined prostaglandin Ei-bradykinin infusion. There was a small increase in forelimb weight during the prostaglandin Ei infusion, a large increase in forelimb weight during the bradykinin infusion, and a massive in-crease in forelimb weight during the combined prostaglandin Ei-bradykinin infusion. The increases in lymph flow, lymph total protein concentration, and total protein transport produced by prostaglandm E[ were small, by bradykinin very large, and those produced by the combined prostaglandin Ej-bradykinin infusion (except for total protein concentration) were exceptionally marked.
Responses in Forelimbs Perfused at Constant Pump-Controlled Inflow
Effects of Prostaglandin £\, Histamine, and Bradykinin on Vascular Pressure, Lymph, and Weight (Table 2) Mean aortic pressure, skin small vein pressure, and plasma total protein concentration were not significantly affected during the infusions of prostaglandin Ei, histamine, or bradykinin. All agents studied produced decreases in perfusion pressure which were sustained (prostaglandin Ei and histamine) or transient (bradykinin). The infusions of histamine or bradykinin produced large dose-related increases in lymph flow, lymph total protein concentration, total protein transport, and forelimb PGEi-4 -prostaglandin Ei, 4 itg/min, la, from 0 to GO minutes (n -6), H-4 -huurnine, 4 fig baae/min, ia, from 0 to 60 minutes (n -6), H-16hutamine, 16 fif ba*e/min, m, from 0 to 60 minutes (n -6), B-.8 -bradykinin, 0.8 jig bose/min ia, from 0 to flO minutes (n " 8), B-10 = bradykinin, 10/ig baae/min, u, from 0 to 60 minutes (n -6). The mean weight of the experimental forelimbs eiceeded the mean weight of the contralateral forelimbs by 23 ± 4 g", 38 ± 4 g", 70 ± 7 g*, 14 ± 3 g * , and 130 ± 7 g' after the cessation of the prostajlanrlin E,, but*muie-4, hKtflmine-16, brmdykinin-.8, and bradyltinin-10 infiifiionB, respectively ' P < 0.01 relative to -10 to 0 minute time. t P < 0.05 relative to -10 to 0 minute time. VOL. 49, No. 2, AUGUST 1981 weight. The infusion of prostaglandin Ei produced only small increases in these parameters. (Table 3) Prostaglandin Ei, 4 ng/min, infused together with histamine, 16 jug base/min, or bradykinin, 10 fig base/min, locally ia for 60 minutes failed to alter mean aortic pressure or plasma total protein concentration significantly. Perfusion pressure was decreased, whereas skin small vein pressure was gradually increased, especially during the prostaglandin Ei-bradykinin combined infusion. Lymph flow, lymph total protein concentration, total protein transport, and forelimb weight were increased markedly during both combined infusions. The increases in lymph flow, total protein transport, and forelimb weight were far greater than those produced by prostaglandin E,, histamine, or bradykinin, alone or additively. (Table 4) The infusion of histamine, 4 fig baae/min, together with bradykinin, 0.8 jug/min or 10 \i% base/ min, locally ia for 60 minutes failed to alter mean aortic pressure or plasma total protein concentration significantly. Lymph total protein concentra- tion was increased markedly during both combined infusions. Perfusion pressure was decreased and skin small vein pressure was increased, especially during the combined infusions with the high dose of bradykinin. Lymph flow, total protein transport, and forelimb weight were markedly increased during both infusions, and the increase was gTeater than that produced by histamine or bradykinin alone or additively.
Interaction between Prostaglandin Ei and Histamine or Bradykinin
Interaction between Histamine and Bradykinin
Control Forelimb Weights
The mean weight of the contralateral control forelimbs of all animals employed in this study was 558 ± 16 g. There was no significant difference among the mean weights of the contralateral control forelimbs among the various groups used in this study.
Discussion
Sixty-minute local intra-arterial infusions of histamine or bradykinin into forelimbs pump perfused at constant inflow produced dose-related increases in lymph flow, lymph total protein concentration, total protein transport, and weight similar to that previously reported (Grega et al., 1972a; Kline et al., 1973; Marciniak et al., 1978; Maciejko et aL, 1978; Svensjo et al., 1979; Grega et al., 1980; Raymond et al., 1980) . The weight increases are attributable to edema formation subsequent to a fall in the transmural colloid osmotic pressure gradient owing to an increase in microvascular permeability to macromolecules. This is evidenced by the marked rise in lymph total protein concentration and lymph flow rate. Because the blood pump prevents arterial blood flow from increasing as it does under natural flow conditions, a rise in capillary hydrostatic pressure subsequent to arteriolar vasodilation would not be expected in forelimbs pump perfused at a constant flow rate. In naturally perfused forelimbs, 60-minute local intra-arterial infusions of bradykinin produced even more marked increases in edema and lymph flow, and accelerated the rate of weight gain and the rate of protein efflux compared to that in forelimbs pump perfused at constant inflow. This reflects the contribution of the increase in capillary hydrostatic pressure superimposed on the increase in microvascular permeability to macromolecules which further enhances the rate of net fluid filtration (Kline et al., 1973) .
Local intra-arterial infusions of prostaglandin Ei for 60 minutes produced increases in weight, lymph total protein concentration, and lymph flow in fore- VOL. 49, No. 2, AUGUST 1981 limbs perfused naturally or at constant pump controlled inflow. The increase in weight is attributable to edema formation subsequent to an increase in microvascular permeability to macromolecules. In the naturally perfused forelimbs, an increase in microvascular pressure subsequent to arteriolar vasodilation would also contribute to the edema formation. Thus, as histamine and bradykinin, prostaglandin Ei produces an increase in macromolecular permeability to plasma proteins. This conclusion is supported by the observation that other vasodilator drugs which do not alter macromolecular permeability fail to increase lymph total protein concentration, and do not produce edema formation when the forelimb is perfused at constant pump controlled inflow Marciniak et al., 1978; Grega et al., 1980; . It was also observed that increasing the prostaglandin E, infusion rate did not produce doserelated increases in protein efflux and edema formation as does histamine and bradykinin. Thus, these data are in agreement with others suggesting that the direct action of proataglandin Ei on the microvascular membrane is weak relative to that of histamine and bradykinin (Freeman and West, 1972; Williams and Morley, 1973; Vane, 1976; Svensjo, 1978) .
The failure of other investigators (Greenberg and Sparks, 1969; Daugherty, 1971; Joyner, 1977) to find evidence of a direct action of prostaglandin Ei on the microvascular membrane in the dog is probably related to the small doses studied. For example, Joyner (1977) reported that, in the dog, intradermal injections of prostaglandin Ei increased the efflux rate of labeled albumin as did histamine, evidence for an increase in microvascular permeability to plasma proteins. However, in the limb, subcutaneous injections of substantially smaller doses of prostaglandin Ei did not increase the concentration of proteins in lymph, thus providing no evidence for an increase in microvascular permeability to macromolecules. The differences, therefore, are likely related to dose.
The infusion of prostaglandin Ei together with either histamine or bradykinin produced massive increases in forelimb weight owing to edema formation. The edema greatly exceeded that produced by prostaglandin Ei and histamine or bradykinin alone or additively. The rate of edema development was very rapid during the combined infusions. For example, during the prostaglandin Ei-bradykinin infusion, the forelimbs were frequently massively edematous in less than 10 minutes under both natural or constant pump controlled flow conditions. The edema was visibly evident, and characterized by a spreading of the digits. During the infusion of bradykinin alone, it usually took more than 30 minutes to detect visible signs of edema formation. The edema was associated with exceptionally marked increases in lymph flow, lymph total protein concentration, and total protein transport, and is attributable to a very dramatic increase in microvascular permeability to macromolecules which greatly increases net protein efflux. The edema was frequently so massive (especially during the prostaglandin Ei-bradykinin infusion) that venous pressure increased with time even in the forelimba pump perfused at a constant flow rate. The increased venous pressure is attributable to extravascular compression subsequent to marked increases in interstitial fluid volume. This is suggested because, on cessation of the infusion, perfusion pressure promptly returned to control, but venous pressure failed to decrease. In those experiments in which the edema formation was more modest, there was no increase in venous pressure. Moreover, neither bradykinin, histamine, nor prostaglandin Ei infused alone produced increases in skin small vein pressure in forelimbs pump perfused at constant inflow. The potentiation of the bradykinin-induced edema formation produced by prostaglandin Ei is in agreement with that reported by many others in rats, hamsters, and guinea pigs (Williams and Morley, 1973; Ikeda et al., 1975; Vane, 1976; Williams and Peck, 1977) . However, some investigators have not been able to demonstrate a potentiation of histamine-induced edema formation by prostaglandin E] (Lewis et al., 1974; Thomas and West, 1974; Vane, 1976) . The reason for this is not clear.
These data provide evidence that the potentiation of the histamine and bradykinin edema formation produced by prostaglandin Ei results from a direct interaction of these agents on the microvascular membrane which further increases microvascular permeability to macromolecules, thus dramatically increasing the efflux rate of plasma proteins from the microcirculation (Svensjo, 1978; Joyner et al., 1979) . These data do not support the conclusions of some other investigators who suggested that the potentiation of the bradykinin edema formation produced by prostaglandin Ei results simply from the arteriolar vasodilator action of this agent which further increases blood flow (Williams and Morley, 1973; Williams and Peck, 1977; Kopaniak et al., 1978) . These conclusions are based on the following observations. The potentiation of the edema formation was equally marked in naturally perfused forelimbs in which blood flow markedly increases (Daugherty, 1971) , and in pump-perfused forelimbs in which an increase in blood flow is mechanically prevented by the pump. Other vasodilators in doses which produce vasodilation equal to that produced by prostaglandin Ei do not potentiate the edema produced by histamine and bradykinin Svensjo et al., 1978; Svensjo et al., 1979; Joyner et al., 1979; Grega et al., 1980; . The very potent arteriolar vasodilator isoproterenol, in fact, prevents the edema formation produced by histamine or bradykinin, and by combined infusions of prostaglandin Ei and bradykinin (unpublished observation). Svensjo (1978) and Joy-ner et al. (1979) have demonstrated by intra-vital light microscopy that prostaglandin Ej and bradykinin increase the number of large venular gaps through which labeled macromolecules rapidly escape from the microcirculation. The development of the large venular gaps is due to endothelial cell separations in the postcapillary venules, and is not influenced by even major changes in blood flow. Moreover, the number of large venular gaps formed by prostaglandin Ei and bradykinin given together greatly exceeds that produced by either agent administered alone. The data in this study are consistent with the accelerated opening of many large pores, owing to an interaction among the inflammatory mediators at the level of the microvascular membrane, despite the fact that in the forelimbs perfused at constant inflow-the pump mechanically prevents blood flow from increasing. Williams and Morley (1973) , Williams and Peck (1977) , and Kopaniak et al. (1978) did not eliminate the possibility that the potentiation of the bradykirun-induced edema formation by prostaglandin Ei resulted from a direct action on the microvascular membrane independent of the increase in blood flow. These investigators simply noted that the potentiation produced by prostaglandin Ei was greatest at doses which produced maximal vasodilation. In this study, it was noted that prostaglandin Ei produced measurable increases in lymph total protein concentration only in doses exceeding those which produced maximal vasodilation.
A microvascular interaction between histamine and bradykinin also was observed in this study. The edema produced by combined infusions of histamine and bradykinin greatly exceeded that produced by infusions of histamine or bradykinin alone, and was associated with marked increases in lymph total protein concentration, lymph flow, and total protein transport. The increases in lymph flow and total protein transport exceeded those produced by histamine or bradykinin alone or additively. During the combined histamine-bradykinin (low dose) infusion, there was no increase in venous pressure. However, during the combined infusion with the high dose of bradykinin, venous pressure increased with time owing to extravascular compression subsequent to increases in interstitial fluid volume. In those experiments in which the edema was more modest, a rise in venous pressure did not occur, although potentiation of the edema formation was still evident.
These data demonstrate that, as interactions among vasoactive agents occur which affect vascular smooth muscle contractility, interactions also occur at the level of the microvascular membrane which affect macromolecular permeability. These microvascular interactions may modulate the increases in microvascular permeability to macromolecules produced by inflammatory mediators either antagonizing or potentiating the increased protein efflux and edema formation produced by histamine-like agents. The catecholamines and vasopressin function as antagonists of the direct action of the inflammatory mediators on the microvascular membrane, whereas the E type prostaglandins function as potentiatora of the inflammatory process. Moreover, the data in this study also demonstrate that a microvascular interaction between histamine and bradykinin occurs which greatly enhances protein efflux and facilitates edema formation. Thus, the existing physiological state may profoundly influence the direct response of the inflammatory mediators on the microvascular membrane. For example, perfusion of the forelimb with blood from animals subject to severe bleeding negates the direct action of histamine-like agents on the microvascular membrane, even if forelimb blood flow is held constant with a blood pump (Marciniak et al., 1977) . The microvascular response to intraarterial and intravenous histamine is dramatically different. Intravenously infused histamine, even in massive concentrations, produces extravascular fluid reabsorption rather than edema formation (Grega et al., 1972b; Marciniak et al. 1977) , in part, subsequent to activation of the sympathoadrenal system.
